Return to the Table of Contents
Topics Covered in this section:
DDSP GENERAL TECHNICAL INFORMATION 9.1: Is the Joint Commission going to allow resubmission of previously reported data as in the past with DDSP submissions? 9.2: What is the difference between uploading data and submitting eCQM data on the DDSP? 9.3: What is a QRDA file? 9.4: For eCQM submission, will we send you the same QRDA I documents that we send to CMS? 9.5: Can vendors have access to the DDSP to test their QRDA I documents so they may address potential errors? 9.6: For eCQM submission, should we run the QRDA I document through the CMS PSVA tool first? 9.7: For eCQM submission, is there an acceptable number or percentage of QRDA I document rejections when submitting to the DDSP? 9.8: For eCQM submission, if QRDA I document(s) are rejected, do you need to resubmit the complete zip file or just the corrected QRDA I document(s)? 9.9: Does the Joint Commission accept QRDA III documents and what is the difference between QRDA I and QRDA III? 9.10 For eCQM submission, Does the DDSP provide a trial/test capability? 9.11: Which version of eCQMs, HL7 standards, EHR Certification Versions, and CMS Implementation Guides must be utilized by HCOs reporting on eCQMs for 2021 and 2022? 9.12: Is the Joint Commission aligned with CMS on the usage of HL7’s Clinical Quality Language (CQL)? The Joint Commission is aligned with CMS on the usage of HL7’s Clinical Quality Language (CQL) standard. 9.13: Will the eCQMs be de-identified data submission? 9.14: Is there a minimum number of patients required to be in the measure population for a HCOto submit data to The Joint Commission? 9.15: Does The Joint Commission have a case threshold (five or fewer) exemption and/or a zero-denominator attestation like CMS? End of Section: ORYX FAQs
Return to the Table of Contents